Parkinson: One shot a week: How weekly Parkinson’s injection would be a game-changer for patients
A groundbreaking weekly injection is ready to change the treatment of Parkinson's by integrating several daily medicines into a single shot. Developed by researchers at the University of South Australia, adding biodegradable gel Levodopa and carbidopa to a Citu -Depot that releases medicines over seven days in a row. The first laboratory results suggest that it gradually distributes more than 90% Levodopa and 81% carbidopa, with more than 80% gelfall over a week, and insignificant toxicity. Managed with a fine 22 measurement meter needle under the skin or in the muscles, simplifies the dose, reduces ups and downs, avoids surgical transplant and increases patient compliance - especially older individuals and those struggling with the ball. Researchers have submitted an Australian patent and have soon planned clinical studies of humans, providing hope for millions of people around the world and possible adaptation for other older conditions.
The Key points
- Weekly dose innovation takes several daily pills with an injection.
- Biodegradable polymergel provides medication for seven days in a row.
- Gel biological decompositions> 80%, no harmful residue within seven days.
- Minimum discomfort injection uses a nice 22 gauge needle.
- Standing plasma medicine levels reduce motor fluctuations and side effects.
- Better farming, ideal or swallowing problems for the elderly.
- Clinical tests next to expanding other chronic diseases are possible.
Disclaimer: This preview includes title, image, and description automatically sourced from the original website (timesofindia.indiatimes.com) using publicly available metadata / OG tags. All rights, including copyright and content ownership, remain with the original publisher. If you are the content owner and wish to request removal, please contact us from your official email to no_reply@newspaperhunt.com.
